WG3
Clinical significance and applications of (epi)lipidomics
Clinical significance and applications of (epi)lipidomics
To establish a roadmap for clinical translation of MS-based lipidomics by bringing together participants working in clinical diagnostic and laboratory medicine, clinicians, researchers involved in method development and validation, biostatisticians and commercial enterprises developing lipid standards and diagnostic kits. The main focus of WG3 is a network – and community – wide assessment of the putative implementation strategies of lipid derived markers in clinical workflows considering analytical and clinical performance, clinical and cost effectiveness, and impact.
Matej Orešič
University of Turku (Finland), and associate professor at Örebro University (Sweden)
Margrét Thorsteinsdóttir
University of Iceland, Reykjavík, Iceland